论文部分内容阅读
2008年1月23日,从美国北卡罗来纳州的威尔明顿传来喜讯,全球领先的药物研发外包服务组织PPD(约46亿美元市值的纳斯达克上市公司)宣布与北京协和洛奇生物医药科技发展有限公司(简称协和洛奇)签订独家合作协议,双方将在中关村生命科学园合作建设全球中心实验室。实验室建成后,协和洛奇不但可为PPD在华的临床研究提供临床化学,
On January 23, 2008, good news came from Wilmington, North Carolina, the world’s leading drug development outsourcing service organization PPD (NASDAQ listed company with a market capitalization of about $ 4.6 billion) announced that it has signed a contract with Beijing Concord Lodge Biomedical Technology Development Co., Ltd. (Concorde Lodge) signed an exclusive cooperation agreement, the two sides will Zhongguancun Life Science Park in the construction of a global center of laboratory cooperation. After the completion of the laboratory, Concord Lodge will not only provide clinical chemistry for the clinical study of PPD in China,